This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN H. RAAF, MD, DPHIL; JEANNE ENNIS, RN
New York

Arch Surg. 1982;117(4):514-515.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—Long-term, intermittent administration of chemotherapy to patients with cancer is often difficult due to previous sclerosis of the peripheral surface veins by antineoplastic agents. Patients are then subjected to several unsuccessful attempts at venipuncture each time they receive chemotherapy and are at increased risk for extravasation, with subsequent tissue damage.

We have used two methods to solve this problem. A patient with poor veins who is likely to require chemotherapy on a long-term basis (six months or more) as an outpatient or inpatient receives either a Broviac (or Hickman) central venous catheter (useful especially in children [B. Eisenberg, MD, P. R. Exelby, MD, J. H. Raaf, MD, unpublished observation]), or a polytetrafluoroethylene (PTFE) arteriovenous graft placed in the arm or leg.¹ The choice between these two techniques may be difficult, and depends on such factors as patient reliability, availability of personnel to manage catheter complications, and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?